Gabriela Valle-Núñez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gabriela Valle-Núñez has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Diana L. Prado-Romero
DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico
2 shared publications - Jose Luis Medina Franco
Universidad Nacional Autónoma de México
2 shared publications - Juan Felipe Avellaneda-Tamayo
DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico
2 shared publications Raziel Cedillo-González
DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico
2 shared publicationsFernanda I. Saldívar-González
DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico
1 shared publication- Fernanda Isabel Saldívar-González
Universidad Nacional Autónoma de México
1 shared publication
Latest Publications
- Open Access
- 4 April 2025
- Published by Royal Society of Chemistry (RSC) in Digital Discovery
- Vol. 4 (5) , 1239-1258
Machine learning-driven antiviral libraries targeting respiratory viruses
Viral infections represent a significant global health concern.
- 4 April 2025
- Published by Royal Society of Chemistry (RSC) in Digital Discovery
- Vol. 4 (5) , 1239-1258
Open AccessMachine learning-driven antiviral libraries targeting respiratory viruses
Viral infections represent a significant global health concern.
- Open Access
- 4 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Machine learning-driven antiviral libraries targeting respiratory viruses
Viral infections represent a significant global health concern; therefore, herein we seek to design compound libraries with prospective antiviral activity. Viral diseases can range from mild symptoms to life-threatening conditions, and the impact of these infections has grown due to increased contagious rates driven by globalization. A prime example is the SARS-CoV-2 pandemic, which emphasized the urgent need to design and develop new antiviral drugs. This study aimed to generate a curated data set of compounds relevant to respiratory infections, focusing on predicting their antiviral activity. Specifically, the study leverages ML classification models to evaluate focused and on-demand compound libraries targeting pathways associated with viral respiratory infections. ML models were trained based on the antiviral biological activity related to respiratory diseases deposited on a major public compound database annotated with biological activity. The models were validated and retrained to classify and design antiviral-focused libraries on seven respiratory targets.
- 4 February 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessMachine learning-driven antiviral libraries targeting respiratory viruses
Viral infections represent a significant global health concern; therefore, herein we seek to design compound libraries with prospective antiviral activity. Viral diseases can range from mild symptoms to life-threatening conditions, and the impact of these infections has grown due to increased contagious rates driven by globalization. A prime example is the SARS-CoV-2 pandemic, which emphasized the urgent need to design and develop new antiviral drugs. This study aimed to generate a curated data set of compounds relevant to respiratory infections, focusing on predicting their antiviral activity. Specifically, the study leverages ML classification models to evaluate focused and on-demand compound libraries targeting pathways associated with viral respiratory infections. ML models were trained based on the antiviral biological activity related to respiratory diseases deposited on a major public compound database annotated with biological activity. The models were validated and retrained to classify and design antiviral-focused libraries on seven respiratory targets.